Keyword: Sucampo Pharmaceuticals

Mallinckrodt, which has landed in hot water multiple times this year, is diversifying beyond its controversial lead seller.

Several exclusions in Express Scripts' new formulary, or a lack thereof in some fields, highlight trends in the drug business.